Capital Signal

Argent Biopharma Limited (ASX: RGT)

Sector: Health Care

Market cap: A$3M (as of 2 Nov 2026)

A clinical stage, revenue generating biopharmaceutical company. Committed to providing accessible medical treatments for unmet medical needs.

Data as of 2 Nov 2026.

Recent capital raises

DateTypeAmountPriceDiscountSource
7 Jan 2025Placement$4.5M$0.40370% premiumFiling ↗
24 Oct 2024Placement$0.2M$0.3028.4% discountFiling ↗
16 July 2024Placement$2M$0.80397% premiumFiling ↗
1 July 2024Placement$0.5M$1.20400% premiumFiling ↗
1 Nov 2023Placement$7.9M$0.26—Filing ↗

Substantial holders — latest moves

DateHolderMoveHoldingSource
29 Aug 2025A2 Invest LLCEntry?% → 15.59%Filing ↗
15 Oct 2024—Entry—Filing ↗
8 Sept 2023Premier Fund Managers LtdDecrease9.862551% → 8.67%Filing ↗
19 July 2023Premier Fund Managers LtdIncrease5.59% → 9.862551%Filing ↗
18 Apr 2023Premier Fund Managers LtdEntry?% → 5.59%Filing ↗

Director trades — on-market

DateDirectorTradeSource
6 May 2022Stephen Barry ParkerBought 1,111,111Filing ↗
6 May 2022Roby Reuven ZomerBought 819,672Filing ↗
30 Sept 2021Evan HayesBought 295,000Filing ↗
5 Mar 2021Stephen Barry ParkerBought 282,316Filing ↗
8 Feb 2019Nativ SegevBought 500,000 Ordinary SharesFiling ↗

Cash and runway

MetricValueAs ofSource
CashA$11K30 Sept 2026Filing ↗
Runway0 quarters30 Sept 2026Filing ↗

Ask about RGT in Claude or ChatGPT

Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:

  • Has RGT raised money in the last year, and at what discount?
  • What was RGT's latest cash position and runway?

Setup guide for Claude, ChatGPT and other MCP clients →

Loading RGT…

Argent Biopharma Limited (ASX: RGT): capital raises, holders, director trades | Capital Signal